ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0190

Effect of Shared Decision-making on Trust in Physician in the Clinical Practice of Systemic Lupus Erythematosus: The TRUMP2-SLE Study

Ryusuke Yoshimi1, Chiharu Hidekawa2, Natsuki Sakurai3, Nobuyuki Yajima4, Noriaki Kurita5, Naoki Suzuki3, Yuji Yoshioka3, Daiga Kishimoto6, Noriko Kojitani3, Yumiko Sugiyama3, Yosuke Kunishita7, Kana Higashitani3, Yuji Uzawa3, Yuichiro Sato3, Soichiro Adachi3, Yuki Iizuka3, Ayaka Maeda3, Lisa Hirahara3, Takaaki Komiya3, Yutaro Soejima3, Naoki Hamada3, Hideto Nagai3, Naomi Tsuchida3, Kaoru Takase-Minegishi3, Yohei Kirino3, Nao Oguro4, Keigo Hayashi8, Kenta Shidahara8, Yoshia Miyawaki8, Ken-ei Sada9, Dai Kishida10, Takanori Ichikawa11, Yasuhiro Shimojima10, Yuichi Ishikawa12, Shigeru Ohno13 and Hideaki Nakajima3, 1Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanazawa Ward, Yokohama Kanagawa, Japan, 2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama City, Kanagawa Prefecture, Japan, 3Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan, 4Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, 5Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan, 6Center for Rheumatic Diseases, Yokohama City University Medical Center, Kanazawa-ku Yokohamashi, Japan, 7Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan, 8Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 9Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Okayama, Japan, 10Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan, 11Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, 12First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyusyu Fukuoka, Japan, 13Center for Rheumatic Disease, Yokohama City University Medical Center, Yokohama, Japan

Meeting: ACR Convergence 2022

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: In recent years, one of the overarching principles of EULAR recommendation is that systemic lupus erythematosus (SLE) treatment should be based on shared decision-making (SDM) between patients and physicians. However, it is unclear whether the degree of involvement of SLE patients in SDM contributes to their level of trust in their physicians. In this multicenter study, we investigated the relationship between the degree of involvement in SDM and the level of trust in physicians.

Methods: We collected data on the SDM-Q-9 shared decision-making scale (range 0-100), the Trust in Physician scale (TIPS; range 0-100), the Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) for interpersonal trust in a physician (range 0-100), and the A-WFPTS for trust in the medical profession (range 0-100), in SLE patients aged 20 years or older who met the 1997 ACR revised classification criteria and were attending five facilities in Japan. We cross-sectionally examined the association between the SDM-Q-9 and each trust scale. In multiple regression analysis, we used age, sex, disease duration, SLE disease activity index, annual income, level of education, and marital status as adjusting variables, and missing values were complemented by multiple imputations.

Results: A total of 386 SLE patients (age 46.2 ± 14.3 years, 88.3% female) completed the questionnaire of this study. The SDM-Q-9 was positively correlated with three trust scales, TIPS, A-WFPTS for interpersonal trust in a physician, and A-WFPTS for trust in the medical profession (Spearman rank correlation coefficient rs = 0.64 [95%CI 0.57-0.70], p < 0.0001, rs = 0.69 [95%CI 0.63-0.74], p < 0.0001, and rs = 0.47 [95%CI 0.39-0.55], p < 0.0001, respectively). When 351 patients who did not have missing data in SDM-Q-9 and TIPS were divided into two groups, the higher SDM group (185 patients, median 87 [IQR 80-96]) and the lower SDM group (166 patients, 60 [51-67]), the higher SDM group had significantly higher TIPS than the lower SDM group (75 [68-82] vs. 66 [59-68], p < 0.0001). Multiple regression analysis showed that TIPS increased by 2.74 (95%CI 2.32-3.15, p < 0.001) for every ten increases in SDM-Q-9. Similarly, a multiple regression analysis of 366 patients who did not have missing data in SDM-Q-9 and A-WFPTS for interpersonal trust in a physician showed that A-WFPTS increased by 5.08 (95%CI 4.40-5.75, p < 0.001) for every ten increases in SDM-Q-9. Multiple regression analysis of 369 patients who did not have missing data in SDM-Q-9 and A-WFPTS for trust in the medical profession showed that A-WFPTS increased by 4.24 (95%CI 3.30-5.19, p < 0.001) for every ten increases in SDM-Q-9.

Conclusion: The degree of involvement of SLE patients in SDM was associated with their trust in their physicians and doctors in general.


Disclosures: R. Yoshimi, None; C. Hidekawa, None; N. Sakurai, None; N. Yajima, None; N. Kurita, None; N. Suzuki, None; Y. Yoshioka, None; D. Kishimoto, None; N. Kojitani, None; Y. Sugiyama, None; Y. Kunishita, None; K. Higashitani, None; Y. Uzawa, None; Y. Sato, None; S. Adachi, None; Y. Iizuka, None; A. Maeda, None; L. Hirahara, None; T. Komiya, None; Y. Soejima, None; N. Hamada, None; H. Nagai, None; N. Tsuchida, None; K. Takase-Minegishi, Gilead, Daiichi Sankyo, Mitsubishi Tanabe; Y. Kirino, None; N. Oguro, None; K. Hayashi, None; K. Shidahara, None; Y. Miyawaki, None; K. Sada, None; D. Kishida, None; T. Ichikawa, None; Y. Shimojima, None; Y. Ishikawa, None; S. Ohno, None; H. Nakajima, None.

To cite this abstract in AMA style:

Yoshimi R, Hidekawa C, Sakurai N, Yajima N, Kurita N, Suzuki N, Yoshioka Y, Kishimoto D, Kojitani N, Sugiyama Y, Kunishita Y, Higashitani K, Uzawa Y, Sato Y, Adachi S, Iizuka Y, Maeda A, Hirahara L, Komiya T, Soejima Y, Hamada N, Nagai H, Tsuchida N, Takase-Minegishi K, Kirino Y, Oguro N, Hayashi K, Shidahara K, Miyawaki Y, Sada K, Kishida D, Ichikawa T, Shimojima Y, Ishikawa Y, Ohno S, Nakajima H. Effect of Shared Decision-making on Trust in Physician in the Clinical Practice of Systemic Lupus Erythematosus: The TRUMP2-SLE Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/effect-of-shared-decision-making-on-trust-in-physician-in-the-clinical-practice-of-systemic-lupus-erythematosus-the-trump2-sle-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-shared-decision-making-on-trust-in-physician-in-the-clinical-practice-of-systemic-lupus-erythematosus-the-trump2-sle-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology